Apiam Animal Health (ASX:AHX) - Managing Director, Dr Chris Richards
Managing Director, Dr Chris Richards
Source: Finance News Network
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Apiam Animal Health (AHX) has successfully completed an institutional placement and raised $6 million
  • All up, 7.5 million fully-paid ordinary shares were issued to institutional investors at 80 cents
  • This price equated to a 5.9 per cent discount to Apiam’s last trading price of 85 cents on April 14
  • Apiam will use the funds to speed up its regional expansion and assess new acquisition opportunities
  • Shares in Apiam are down a slight 1.18 per cent and are trading at 84 cents

Apiam Animal Health (AHX) has successfully completed an institutional placement and raised $6 million.

All up, 7.5 million fully-paid ordinary shares were issued to institutional investors at 80 cents.

This price represents a 5.9 per cent discount to Apiam’s last trading price of 85 cents on April 14, and a 5.6 per cent discount to the 10-day volume-weighted average price.

Apiam will use the funds to speed up its regional expansion and assess new acquisition opportunities.

Recently, there has been a rapid acceleration in pet ownership in regional areas, creating a favourable veterinary market.

Due to this, Apiam has opened two new purpose-built clinics in Shepparton and Torquay North in Victoria.

“The rapid growth in pet and production animal ownership in regional corridors, particularly as a result of changing population demographics and favourable seasonal corridors, has presented a very exciting market opportunity for Apiam,” Managing Director Dr Chris Richards commented.

“This placement will support us in accelerating our regional expansion plans and capturing the significant growth we are seeing in many veterinary areas,” he said.

“As an established regional player, Apiam is well placed to scale-up and leverage these opportunities as they emerge,” he added.

Shares in Apiam are down a slight 1.18 per cent and are trading at 84 cents at 3:56 pm AEST.

AHX by the numbers
More From The Market Online

This stock provides Oz’s only HIV self-test kit – and it’s bullish on the budget

Atomo Diagnostics is the only company in Australia that provides TGA-approved HIV self-test kits. It says…

Recce Pharma heading closer to full efficacy data for flagship R327

Recce Pharma has announced the latest cohort of patients in the company's Phase I/II UTI trial…
The Market Online Video

Breaking barriers in cancer treatment: Race Oncology pioneers a new era with bisantrene

Race Oncology (ASX:RAC) has announced positive results in killing cancer cells in combination with the drug…

Optiscan agreement with Mayo Clinic aims to expedite robotic surgery

Optiscan Imaging is parterning with Mayo Clinic to develop a digital confocal laser endomicroscopic imaging system